Elective stent-graft treatment for the management of thoracic aorta mural thrombus.
BACKGROUND
Optimal management of aorta mural thrombus (AMT) continues to be controversial. The aim of this study was to describe the management of AMT in the thoracic aorta with either conservative or stent-graft treatment and to analyze the role of morphological characteristics of thrombus in the selection of suitable candidates for intervention.


METHODS
A retrospective review was conducted of all patients admitted for thoracic AMT. Clinical data, treatment used, and outcomes were recorded. Patients were divided in two groups according to the treatment used: either conservative or stent-graft. Morphological features of thrombus, including size, sessile or pedunculated aspect and mobility, were compared between the two groups.


RESULTS
From January 2006 to March 2013, 13 consecutive patients (nine male, mean age 53, range 37-76) were admitted for symptomatic (n = 8) or asymptomatic AMT (n = 5). All patients received unfractionated heparin. Management of primary aortic thrombus required stent-graft in seven patients, aortic thrombectomy in one, and anticoagulation therapy alone in five. Indications for intervention were recurrent embolism (n = 4), occurrence of embolism under heparin (n = 1), or persistent thrombus (n = 2). Endovascular exclusion of AMT was successful in all cases, with no complications or deaths at 30 days and no recurrence at midterm. Analysis of the morphological features of the thrombus identified solely the high degree mobility as associated with adverse outcome (p = .048).


CONCLUSIONS
In our experience, stent-graft exclusion of AMT is an effective approach. Systematic evaluation of thrombus mobility by a real-time imaging study can be helpful to better define the indications for radical treatment of the aortic lesion.
Université de la Méditerranée, Department of Vascular Surgery, University Hospital Nord, Marseille, France. Electronic address: mourad.boufi@ap-hm.fr.
M
M
Boufi
Université de la Méditerranée, Department of Vascular Surgery, University Hospital Nord, Marseille, France.
A
A
Mameli
Université de la Méditerranée, Department of Vascular Surgery, University Hospital Nord, Marseille, France.
P
P
Compes
Université de la Méditerranée, Department of Vascular Surgery, University Hospital Nord, Marseille, France.
O
O
Hartung
Université de la Méditerranée, Department of Vascular Surgery, University Hospital Nord, Marseille, France.
Y S
YS
Alimi
D000328:Adult; D000368:Aged; D000925:Anticoagulants / Q000627:therapeutic use; D001013:Aorta, Thoracic / Q000000981:diagnostic imaging / Q000601:surgery*; D001018:Aortic Diseases / Q000150:complications / Q000601:surgery; D004617:Embolism / Q000209:etiology / Q000628:therapy; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D011859:Radiography; D012189:Retrospective Studies; D055502:Secondary Prevention; D015607:Stents; D013927:Thrombosis / Q000150:complications / Q000628:therapy*; D016896:Treatment Outcome
D000925:Anticoagulants
Aortic mural thrombus; Stentgraft; Thoracic aorta